SF

Sarofim Fayez Portfolio holdings

AUM $20.5B
This Quarter Est. Return
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$20.5B
AUM Growth
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
233
New
Increased
Reduced
Closed

Top Buys

1 +$1.73B
2 +$1.39B
3 +$1.27B
4
CVX icon
Chevron
CVX
+$941M
5
MO icon
Altria Group
MO
+$709M

Top Sells

No sells this quarter

Sector Composition

1 Consumer Staples 29.67%
2 Energy 25.65%
3 Financials 11.32%
4 Healthcare 9.87%
5 Technology 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMCX icon
126
AMC Networks
AMCX
$324M
$1.49M 0.01%
+21,690
YUM icon
127
Yum! Brands
YUM
$41.4B
$1.48M 0.01%
+28,898
RDS.B
128
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$1.48M 0.01%
+21,458
CVC
129
DELISTED
CABLEVISION SYS CP NY GRP CL-A
CVC
$1.46M 0.01%
+86,767
GIS icon
130
General Mills
GIS
$25.1B
$1.45M 0.01%
+30,187
C icon
131
Citigroup
C
$176B
$1.44M 0.01%
+29,678
MMC icon
132
Marsh & McLennan
MMC
$87.6B
$1.44M 0.01%
+33,016
CNL
133
DELISTED
CLECO CRP (HOLDING CO)
CNL
$1.41M 0.01%
+31,510
PBR.A icon
134
Petrobras Class A
PBR.A
$77.6B
$1.27M 0.01%
+75,700
NSC icon
135
Norfolk Southern
NSC
$63.3B
$1.25M 0.01%
+16,175
MSGS icon
136
Madison Square Garden
MSGS
$5.23B
$1.19M 0.01%
+28,832
HAL icon
137
Halliburton
HAL
$23B
$1.19M 0.01%
+24,735
BIIB icon
138
Biogen
BIIB
$22.5B
$1.11M 0.01%
+4,600
BDX icon
139
Becton Dickinson
BDX
$50.3B
$1.1M 0.01%
+11,228
CADE icon
140
Cadence Bank
CADE
$7.01B
$1.07M 0.01%
+53,800
GD icon
141
General Dynamics
GD
$92.8B
$1.06M 0.01%
+12,105
BAX icon
142
Baxter International
BAX
$9.19B
$1.02M 0.01%
+28,536
MJN
143
DELISTED
Mead Johnson Nutrition Company
MJN
$928K ﹤0.01%
+12,491
AGN
144
DELISTED
Allergan Inc
AGN
$898K ﹤0.01%
+9,933
LOW icon
145
Lowe's Companies
LOW
$130B
$894K ﹤0.01%
+18,773
NEE icon
146
NextEra Energy
NEE
$172B
$849K ﹤0.01%
+42,364
EQIX icon
147
Equinix
EQIX
$80.2B
$805K ﹤0.01%
+4,385
NKE icon
148
Nike
NKE
$89.4B
$790K ﹤0.01%
+21,760
NOV icon
149
NOV
NOV
$5.55B
$775K ﹤0.01%
+11,005
BMY icon
150
Bristol-Myers Squibb
BMY
$95.1B
$758K ﹤0.01%
+16,374